USANA Health Sciences, Inc. (NYSE:USNA) insider Daniel A. Macuga sold 11,992 shares of the stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $59.00, for a total transaction of $707,528.00. Following the completion of the sale, the insider now directly owns 11,992 shares in the company, valued at $707,528. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Shares of USANA Health Sciences, Inc. (USNA) traded up 0.59% during midday trading on Thursday, hitting $59.80. 59,104 shares of the company’s stock were exchanged. The stock’s 50 day moving average is $59.52 and its 200-day moving average is $60.19. The stock has a market cap of $1.46 billion, a PE ratio of 15.53 and a beta of 1.10. USANA Health Sciences, Inc. has a 1-year low of $52.55 and a 1-year high of $75.00.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Tuesday, July 25th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.06 by $0.08. The company had revenue of $257.10 million during the quarter, compared to analyst estimates of $273.61 million. USANA Health Sciences had a net margin of 9.05% and a return on equity of 25.31%. The company’s revenue was down .5% on a year-over-year basis. During the same period in the prior year, the company earned $2.07 earnings per share. Analysts predict that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current fiscal year.

USANA Health Sciences announced that its board has initiated a stock repurchase plan on Tuesday, July 25th that authorizes the company to repurchase $64.60 million in outstanding shares. This repurchase authorization authorizes the company to purchase up to 46% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: “USANA Health Sciences, Inc. (USNA) Insider Daniel A. Macuga Sells 11,992 Shares of Stock” was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://www.watchlistnews.com/usana-health-sciences-inc-usna-insider-daniel-a-macuga-sells-11992-shares-of-stock/1534651.html.

A number of equities research analysts have commented on the stock. BidaskClub downgraded shares of USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research report on Monday, July 31st. Pivotal Research raised shares of USANA Health Sciences from a “hold” rating to a “buy” rating and increased their price objective for the company from $55.00 to $75.00 in a research report on Wednesday, May 3rd.

Hedge funds have recently bought and sold shares of the stock. USA Financial Portformulas Corp bought a new stake in USANA Health Sciences during the second quarter valued at about $691,000. Phocas Financial Corp. boosted its stake in USANA Health Sciences by 4.7% in the second quarter. Phocas Financial Corp. now owns 125,090 shares of the company’s stock valued at $8,018,000 after buying an additional 5,575 shares in the last quarter. California State Teachers Retirement System boosted its stake in USANA Health Sciences by 0.5% in the second quarter. California State Teachers Retirement System now owns 20,582 shares of the company’s stock valued at $1,319,000 after buying an additional 100 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in USANA Health Sciences by 7.2% in the second quarter. The Manufacturers Life Insurance Company now owns 9,137 shares of the company’s stock valued at $586,000 after buying an additional 616 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its stake in USANA Health Sciences by 711.5% in the second quarter. Arrowstreet Capital Limited Partnership now owns 91,409 shares of the company’s stock valued at $5,859,000 after buying an additional 80,145 shares in the last quarter. 44.73% of the stock is currently owned by hedge funds and other institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.